Fate Therapeutics (FATE) Long-Term Investments (2019 - 2025)
Fate Therapeutics (FATE) posted Long-Term Investments of $1.5 million for Q4 2025, down 85.72% on a QoQ basis from $10.3 million in Q3 2025, and down 94.68% year-over-year from $27.7 million in Q4 2024.
Fate Therapeutics (FATE) Long-Term Investments (2019 - 2025) Analysis & Trends
Fate Therapeutics' Long-Term Investments history runs 7 years deep, the most recent figure standing at $1.5 million for Q4 2025.
- Quarterly Long-Term Investments fell 94.68% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 94.68% YoY) and the FY2025 annual result came in at $1.5 million, down 94.68% from the prior year.
- Long-Term Investments was $1.5 million for Q4 2025 at Fate Therapeutics, down from $10.3 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $149.5 million in Q2 2021 and bottomed at $980000.0 in Q4 2023.
- A 5-year average of $40.5 million and a median of $26.1 million in 2025 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments sank 95.09% — and 2024, when it jumped 2722.14%.
- Fate Therapeutics' Long-Term Investments stood at $100.7 million in 2021, then sank by 95.09% to $4.9 million in 2022, then plunged by 80.17% to $980000.0 in 2023, then soared by 2722.14% to $27.7 million in 2024, then sank by 94.68% to $1.5 million in 2025.
- Business Quant data shows FATE's Long-Term Investments at $1.5 million in Q4 2025, $10.3 million in Q3 2025, and $26.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 10.31 Mn |
| Jun 30, 2025 | 26.10 Mn |
| Mar 31, 2025 | 32.29 Mn |
| Dec 31, 2024 | 27.66 Mn |
| Sep 30, 2024 | 33.61 Mn |
| Jun 30, 2024 | 47.16 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2023 | 980,000.00 |
| Jun 30, 2023 | 7.29 Mn |
| Mar 31, 2023 | 3.91 Mn |
| Dec 31, 2022 | 4.94 Mn |
| Sep 30, 2022 | 13.94 Mn |
| Jun 30, 2022 | 11.93 Mn |
| Mar 31, 2022 | 67.94 Mn |
| Dec 31, 2021 | 100.66 Mn |
| Sep 30, 2021 | 124.88 Mn |
| Jun 30, 2021 | 149.50 Mn |
| Mar 31, 2021 | 98.28 Mn |
| Sep 30, 2020 | 13.23 Mn |